{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T17:36:08Z","timestamp":1775151368168,"version":"3.50.1"},"reference-count":21,"publisher":"Elsevier BV","issue":"8429","license":[{"start":{"date-parts":[[1985,3,1]],"date-time":"1985-03-01T00:00:00Z","timestamp":478483200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet"],"published-print":{"date-parts":[[1985,3]]},"DOI":"10.1016\/s0140-6736(85)92144-0","type":"journal-article","created":{"date-parts":[[2003,10,11]],"date-time":"2003-10-11T11:00:29Z","timestamp":1065870029000},"page":"602-604","source":"Crossref","is-referenced-by-count":214,"title":["RECOMBINANT HUMAN INTERFERON ALFA-A SUPPRESSES HTLV-III REPLICATION IN VITRO"],"prefix":"10.1016","volume":"325","author":[{"given":"DavidD.","family":"Ho","sequence":"first","affiliation":[]},{"given":"TeresaR.","family":"Rota","sequence":"additional","affiliation":[]},{"given":"JoanC.","family":"Kaplan","sequence":"additional","affiliation":[]},{"given":"KevanL.","family":"Hartshorn","sequence":"additional","affiliation":[]},{"given":"CharlaA.","family":"Andrews","sequence":"additional","affiliation":[]},{"given":"RobertT.","family":"Schooley","sequence":"additional","affiliation":[]},{"given":"MartinS.","family":"Hirsch","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/S0140-6736(85)92144-0_BIB1","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1126\/science.6200935","article-title":"Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS","volume":"224","author":"Popovic","year":"1984","journal-title":"Science"},{"key":"10.1016\/S0140-6736(85)92144-0_BIB2","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1126\/science.6200936","article-title":"Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS","volume":"224","author":"Gallo","year":"1984","journal-title":"Science"},{"key":"10.1016\/S0140-6736(85)92144-0_BIB3","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1126\/science.6324345","article-title":"Antibodies reactive with human T-lymphotropic retroviruses (HTLV-III) in the serum of patients with AIDS","volume":"224","author":"Sarngadharan","year":"1984","journal-title":"Science"},{"key":"10.1016\/S0140-6736(85)92144-0_BIB4","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1126\/science.6189183","article-title":"Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS)","volume":"220","author":"Barr\u00e9-Sinoussi","year":"1983","journal-title":"Science"},{"key":"10.1016\/S0140-6736(85)92144-0_BIB5","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1126\/science.6206563","article-title":"Isolation of lymphocytopathic retroviruses from San Francisco patients with AIDS","volume":"225","author":"Levy","year":"1984","journal-title":"Science"},{"key":"10.1016\/S0140-6736(85)92144-0_BIB6","first-page":"603","article-title":"Effect of interferon on retrovirus replication","volume":"41","author":"Pitha","year":"1982","journal-title":"Texas Rep Biol Med"},{"key":"10.1016\/S0140-6736(85)92144-0_BIB7","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1128\/JVI.45.2.489-495.1983","article-title":"Accumulation and breakdown of RNA-deficient intracellular virus particles in interferon-treated NIH 3T3 cells chronically producing Moloney murine leukemia virus","volume":"45","author":"Aboud","year":"1983","journal-title":"J Virol"},{"key":"10.1016\/S0140-6736(85)92144-0_BIB8","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1128\/JVI.50.2.445-450.1984","article-title":"Antiviral and protein-inducing activities of recombinant human leukocyte interferons and their hybrids","volume":"50","author":"Sen","year":"1984","journal-title":"J Virol"},{"key":"10.1016\/S0140-6736(85)92144-0_BIB9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/newbio244102a0","article-title":"Effects of interferon on leukaemia virus activation in graft versus host disease","volume":"244","author":"Hirsch","year":"1973","journal-title":"Nature New Biol"},{"key":"10.1016\/S0140-6736(85)92144-0_BIB10","first-page":"1083","article-title":"Interferon and murine leukemia. VI. Effect of interferon preparations on the lymphoid leukemia of AKR mice","volume":"43","author":"Gresser","year":"1969","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/S0140-6736(85)92144-0_BIB11","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1126\/science.6208608","article-title":"HTLV-III in the semen and blood of a healthy homosexual man","volume":"226","author":"Ho","year":"1984","journal-title":"Science"},{"key":"10.1016\/S0140-6736(85)92144-0_BIB12","doi-asserted-by":"crossref","first-page":"7588","DOI":"10.1073\/pnas.81.23.7588","article-title":"Infection of human endothelial cells by human T-lymphotropic virus type I","volume":"81","author":"Ho","year":"1984","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S0140-6736(85)92144-0_BIB13","first-page":"377","article-title":"Antibodies to a retrovirus etiologically associated with acquired immunodeficiency syndrome (AIDS) in populations with increased incidences of the syndrome","volume":"33","author":"DeJarlais","year":"1984","journal-title":"Morbid Mortal Weekly Rep"},{"key":"10.1016\/S0140-6736(85)92144-0_BIB14","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/312367a0","article-title":"Aetiology of AIDS-antibodies to human T-cell leukaemia virus (type III) in haemophiliacs","volume":"312","author":"Kitchen","year":"1984","journal-title":"Nature"},{"key":"10.1016\/S0140-6736(85)92144-0_BIB15","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1056\/NEJM198411293112206","article-title":"Virologic studies in a case of transfusion-associated AIDS","volume":"311","author":"Groopman","year":"1984","journal-title":"N Engl J Med"},{"key":"10.1016\/S0140-6736(85)92144-0_BIB16","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1126\/science.6091268","article-title":"Suramin protection of T-cells in-vitro against infectivity and cytopathic effect of HTLV-III","volume":"226","author":"Mitsuya","year":"1984","journal-title":"Science"},{"key":"10.1016\/S0140-6736(85)92144-0_BIB17","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/S0140-6736(84)92060-9","article-title":"Ribavirin suppresses replication of lymphadenopathy-associated virus in cultures of human adult T lymphocytes","volume":"ii","author":"McCormick","year":"1984","journal-title":"Lancet"},{"key":"10.1016\/S0140-6736(85)92144-0_BIB18","doi-asserted-by":"crossref","first-page":"549","DOI":"10.7326\/0003-4819-96-5-549","article-title":"Recombinant leukocyte A interferon: pharmacokinetics, single-dose tolerance, and biologic effects in cancer patients","volume":"96","author":"Gutterman","year":"1982","journal-title":"Ann Intern Med"},{"key":"10.1016\/S0140-6736(85)92144-0_BIB19","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJM197908023010501","article-title":"Prevention of reactivated herpes simplex infection by human leukocyte interferon after operation on the trigeminal root","volume":"301","author":"Pazin","year":"1979","journal-title":"N Engl J Med"},{"key":"10.1016\/S0140-6736(85)92144-0_BIB20","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1056\/NEJM198306233082501","article-title":"Effects of interferon-alpha on cytomegalovirus reactivation syndromes in renal transplant recipients","volume":"308","author":"Hirsch","year":"1983","journal-title":"N Engl J Med"},{"key":"10.1016\/S0140-6736(85)92144-0_BIB21","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJM197805042981801","article-title":"Human leukocyte interferon for the treatment of herpes zoster in patients with cancer","volume":"298","author":"Merigan","year":"1978","journal-title":"N Engl J Med"}],"container-title":["The Lancet"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0140673685921440?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0140673685921440?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,3,26]],"date-time":"2020-03-26T01:39:47Z","timestamp":1585186787000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0140673685921440"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1985,3]]},"references-count":21,"journal-issue":{"issue":"8429","published-print":{"date-parts":[[1985,3]]}},"alternative-id":["S0140673685921440"],"URL":"https:\/\/doi.org\/10.1016\/s0140-6736(85)92144-0","relation":{},"ISSN":["0140-6736"],"issn-type":[{"value":"0140-6736","type":"print"}],"subject":[],"published":{"date-parts":[[1985,3]]}}}